Rexgenero-France to present Off-the-Shelf CAR-T Therapy nanoparticle data at PEGS Europe 2020
Rexgenero-France to present Off-the-Shelf CAR-T Therapy nanoparticle data at PEGS Europe 2020 |
Paris, France, 11 November 2020: Rexgenero-France (previously aratinga.bio), a preclinical stage biotech company developing an off-the-shelf and universal chimeric antigen receptor (CAR)-T therapy which allows in vivo targeting and transduction of T-cells, today announces that Dr. Charles DUCHÊNE will present new data at The PEGS Europe Virtual Conference on Wednesday, 11 November, 2020 at 11:35 am CET. |
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506